Copyright
©The Author(s) 2018.
World J Gastroenterol. Mar 21, 2018; 24(11): 1239-1249
Published online Mar 21, 2018. doi: 10.3748/wjg.v24.i11.1239
Published online Mar 21, 2018. doi: 10.3748/wjg.v24.i11.1239
Table 2 Correlation between autotaxin and clinicopathological findings
All (n = 186) | Male (n = 80) | Female (n = 106) | ||||
r | P value | r | P value | r | P value | |
Age (yr) | 0.48 | < 0.001 | 0.45 | < 0.001 | 0.28 | < 0.01 |
BMI (kg/m2) | 0.18 | < 0.05 | 0.06 | NS | 0.31 | < 0.01 |
Platelet (× 104/μL) | -0.32 | < 0.001 | -0.28 | < 0.05 | -0.43 | < 0.001 |
Albumin (g/dL) | -0.32 | < 0.001 | -0.10 | NS | -0.31 | < 0.01 |
AST (IU/L) | 0.31 | < 0.001 | 0.34 | < 0.01 | 0.40 | < 0.001 |
ALT (IU/L) | 0.06 | NS | 0.14 | NS | 0.24 | < 0.05 |
TG (mg/dL) | -0.09 | NS | -0.14 | NS | -0.08 | NS |
LDL-C (mg/dL) | -0.04 | NS | -0.01 | NS | -0.06 | NS |
HDL-C (mg/dL) | 0.13 | NS | -0.04 | NS | -0.04 | < 0.001 |
FBG (mg/dL) | 0.22 | < 0.01 | 0.36 | 0.001 | 0.21 | < 0.05 |
IRI (mU/L) | 0.20 | < 0.01 | 0.15 | NS | 0.31 | 0.002 |
HOMA-IR | 0.22 | < 0.01 | 0.22 | < 0.05 | 0.31 | 0.001 |
Fe (μg/dL) | 0.09 | NS | 0.12 | NS | 0.35 | < 0.001 |
Ferritin (ng/mL) | 0.04 | NS | 0.22 | NS | 0.31 | 0.002 |
HA (ng/mL) | 0.49 | < 0.001 | 0.47 | < 0.001 | 0.46 | < 0.001 |
4C7S (ng/mL) | 0.40 | < 0.001 | 0.30 | < 0.01 | 0.50 | < 0.001 |
FIB-4 | 0.58 | < 0.001 | 0.51 | < 0.001 | 0.60 | < 0.001 |
APRI | 0.43 | < 0.001 | 0.45 | < 0.001 | 0.55 | < 0.001 |
Histological findings | ||||||
Steatosis score | 0.02 | NS | 0.12 | NS | -0.03 | NS |
Lobular inflammation score | 0.22 | < 0.01 | 0.06 | NS | 0.25 | < 0.01 |
Ballooning score | 0.36 | < 0.001 | 0.34 | < 0.01 | 0.38 | < 0.001 |
NAS | 0.27 | < 0.001 | 0.27 | < 0.05 | 0.26 | < 0.01 |
Fibrosis stage | 0.45 | < 0.001 | 0.44 | < 0.001 | 0.53 | < 0.001 |
- Citation: Fujimori N, Umemura T, Kimura T, Tanaka N, Sugiura A, Yamazaki T, Joshita S, Komatsu M, Usami Y, Sano K, Igarashi K, Matsumoto A, Tanaka E. Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease. World J Gastroenterol 2018; 24(11): 1239-1249
- URL: https://www.wjgnet.com/1007-9327/full/v24/i11/1239.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i11.1239